[P26-7] P26-7: Oncologic drugs (3): Pharmaometrics, PK/PD, special population

[P26-7-3] Continuous cytostatic effects of BCR-ABL tyrosine kinase inhibitors(TKIs) after washout in human leukemic K562 cells

Tsuyoshi Aoyama¹, Mitsuru Sugawara², Yoh Takekuma³, Yuki Sato⁴, Masato Sumi⁵ (1.Hokkaido University, 2.Hokkaido University, 3.Hokkaido University, 4.Hokkaido University, 5.Hokkaido University)

Keywords:dasatinib, nilotinib, imatinib, chronic myeloid leukemia, cell viability